Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIPNOL: Combined Monitoring in HIPEC Surgery
NCT04104334Terminated
- Start
- May 2019
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in colorectal cancer (CRC) and peritoneal carcinomatosis (PC) (2 arms). Primary endpoints: Hospital Length of Stay up to 21 days, Tolerance of Oral Intake up to 21 days and 4 more. Started May 2019; status: terminated.
02
Conditions
colorectal cancer (CRC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT04104334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104334.